Finch Therapeutics Group (FNCH) Revenue & Revenue Breakdown
Finch Therapeutics Group Revenue Highlights
Latest Revenue (Y)
$107.00K
Main Segment (Y)
Collaboration Revenue
Finch Therapeutics Group Revenue by Period
Finch Therapeutics Group Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $107.00K | -87.57% |
| 2022-12-31 | $861.00K | -95.35% |
| 2021-12-31 | $18.53M | 140.08% |
| 2020-12-31 | $7.72M | -23.98% |
| 2019-12-31 | $10.15M | - |
Finch Therapeutics Group generated $107.00K in revenue during NA 2023, up -87.57% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Finch Therapeutics Group Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $2.85M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | -100.00% |
| 2023-03-31 | $107.00K | 1237.50% |
| 2022-12-31 | $8.00K | -94.20% |
| 2022-09-30 | $138.00K | -61.77% |
| 2022-06-30 | $361.00K | 1.98% |
| 2022-03-31 | $354.00K | -56.08% |
| 2021-12-31 | $806.00K | -92.89% |
| 2021-09-30 | $11.34M | 300.81% |
| 2021-06-30 | $2.83M | -20.35% |
| 2021-03-31 | $3.55M | 96.62% |
| 2020-12-31 | $1.81M | 2.03% |
| 2020-09-30 | $1.77M | -24.61% |
| 2020-06-30 | $2.35M | 31.08% |
| 2020-03-31 | $1.79M | - |
Finch Therapeutics Group generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Finch Therapeutics Group Revenue Breakdown
Finch Therapeutics Group Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Collaboration Revenue | $861.00K | $18.53M |
| Royalties Revenue From Related Party | - | - |
Finch Therapeutics Group's latest annual revenue breakdown by segment (product or service), as of Dec 22: Collaboration Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue | $107.00K | $8.00K | $138.00K | $361.00K | $354.00K | $806.00K | $11.34M | $2.83M | $3.55M |
Finch Therapeutics Group's latest quarterly revenue breakdown by segment (product or service), as of Mar 23: Collaboration Revenue (100.00%).
Finch Therapeutics Group Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue | $107.00K | $8.00K | $138.00K | $361.00K | $354.00K | $806.00K | $11.34M | $2.83M | $3.55M |
Finch Therapeutics Group's latest quarterly revenue breakdown by geography, as of Mar 23: Collaboration Revenue (100.00%).
Finch Therapeutics Group Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HOWL | Werewolf Therapeutics | $19.94M | $742.00K |
| IKNA | Ikena Oncology | $9.16M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| NTRB | Nutriband | $2.09M | $442.83K |
| LGVN | Longeveron | $709.00K | $548.00K |
| FNCH | Finch Therapeutics Group | $107.00K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| DSGN | Design Therapeutics | - | - |
| CCCC | C4 Therapeutics | - | - |
| DBTX | Decibel Therapeutics | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| ELYM | Eliem Therapeutics | - | - |
| RNXT | RenovoRx | - | - |
| CELC | Celcuity | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| EWTX | Edgewise Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| BWV | Onconetix | - | - |
| XLO | Xilio Therapeutics | - | $2.36M |
FNCH Revenue FAQ
What is Finch Therapeutics Group’s yearly revenue?
Finch Therapeutics Group's yearly revenue for 2023 was $107K, representing a decrease of -87.57% compared to 2022. The company's yearly revenue for 2022 was $861K, representing a decrease of -95.35% compared to 2021. FNCH's yearly revenue for 2021 was $18.53M, representing an increase of 140.08% compared to 2020.
What is Finch Therapeutics Group’s quarterly revenue?
Finch Therapeutics Group's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.84M, a 100.00% increase from the previous quarter (Q3 2023), and a 35462.50% increase year-over-year (Q4 2022). FNCH's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).
What is Finch Therapeutics Group’s revenue growth rate?
Finch Therapeutics Group's revenue growth rate for the last 3 years (2021-2023) was -99.42%, and for the last 5 years (2019-2023) was -98.95%.
What are Finch Therapeutics Group’s revenue streams?
Finch Therapeutics Group's revenue streams in c 22 are Collaboration Revenue
What is Finch Therapeutics Group’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Finch Therapeutics Group was Collaboration Revenue. This segment made a revenue of $861K, representing 100.00% of the company's total revenue.